Interestingly, several studies showed that cardiomyocyte-specific ATGL overexpression chronically reduced TG content in the heart and prevented cardiac dysfunction upon transverse aortic constriction [157], diabetes [158], obesity [159], and doxorubicin [160]. This evidence concerns the gene PNPLA2 and diabetes mellitus.